841 / 1224
Take Home Message
1. Independent assay of RAKR from the manufacturer is required.
2. Calibration methods are established for all brachytherapy sources.
3. Calibration infrastructure (i.e., SSDL availability) is variable.
4. Future improvements forthcoming in calibration methods and infrastructure.